S-Citalopram for the Prevention of PEGASYS-Induced Depression - Related Studies

S-Citalopram for the Prevention of PEGASYS-Induced Depression

This study is ongoing, but not recruiting participants.

Study NCT00136318. Last updated on July 24, 2006. Information provided by Charite University, Berlin, Germany

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Depression

2	Additional conditions recognized in this trial
		Depressive Disorder

3	More general conditions related to this trial
		Behavioral Symptoms
		Mental Disorders
		Mood Disorders

4	Interventions listed in this trial
		S-citalopram

5	Additional drug interventions recognized in this trial
		Citalopram
		Dexetimide
		Peginterferon alfa-2a

6	More general drug interventions related to this trial
		Anti-Dyskinesia Agents
		Anti-Infective Agents
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Antiparkinson Agents
		Antiviral Agents
		Autonomic Agents
		Central Nervous System Agents
		Cholinergic Agents
		Cholinergic Antagonists
		Molecular Mechanisms of Pharmacological Action
		Muscarinic Antagonists
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Parasympatholytics
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		Charite University, Berlin, Germany